M&A TRANSACTION · 2024
Vantive (Baxter Kidney Care Segment) acquired by The Carlyle Group
$3.80B· 0.85x revenue
Target
Vantive (Baxter Kidney Care Segment)
Deerfield, IL
Baxter's kidney care division including dialysis, organ support, and acute renal therapy portfolios
Acquirer
The Carlyle Group
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
$4450.0M
EBITDA
—
Deal Value
$3.80B
EV/EBITDA
—
Context
This $3.80B acquisition of Vantive (Baxter Kidney Care Segment) by The Carlyle Group sits in the medical practice specialty sub-vertical. The Carlyle Group is acquiring as a private equity buyer; see how PE acquirers typically price medical practice specialty businesses on our Medical Practice Specialty PE buyer-pool page.
Source
Data sourced from Baxter Press Release — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical practice specialty
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Vantive (Baxter Kidney Care Segment) acquisition.